Monday, 25 December 2017

La Jolla Pharmaceutical Company Announces Initiation of ... - Nasdaq - Nasdaq


Nasdaq
La Jolla Pharmaceutical Company Announces Initiation of ... - Nasdaq
Nasdaq
SAN DIEGO, Dec. 18, 2017-- La Jolla Pharmaceutical Company today announced the initiation of LJ401-HH01, a Phase 2 clinical study of LJPC- 401 in.

and more »


from phlebotomy - Google News http://bit.ly/2DKANmj
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)